1. Home
  2. EBMT vs CTNM Comparison

EBMT vs CTNM Comparison

Compare EBMT & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBMT
  • CTNM
  • Stock Information
  • Founded
  • EBMT 1922
  • CTNM 2009
  • Country
  • EBMT United States
  • CTNM United States
  • Employees
  • EBMT N/A
  • CTNM 41
  • Industry
  • EBMT Major Banks
  • CTNM
  • Sector
  • EBMT Finance
  • CTNM
  • Exchange
  • EBMT Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • EBMT 127.9M
  • CTNM 142.3M
  • IPO Year
  • EBMT N/A
  • CTNM 2024
  • Fundamental
  • Price
  • EBMT $16.46
  • CTNM $5.77
  • Analyst Decision
  • EBMT
  • CTNM Strong Buy
  • Analyst Count
  • EBMT 0
  • CTNM 4
  • Target Price
  • EBMT N/A
  • CTNM $22.50
  • AVG Volume (30 Days)
  • EBMT 92.7K
  • CTNM 364.9K
  • Earning Date
  • EBMT 08-05-2025
  • CTNM 08-12-2025
  • Dividend Yield
  • EBMT 3.51%
  • CTNM N/A
  • EPS Growth
  • EBMT 26.99
  • CTNM N/A
  • EPS
  • EBMT 1.41
  • CTNM N/A
  • Revenue
  • EBMT $82,271,000.00
  • CTNM N/A
  • Revenue This Year
  • EBMT N/A
  • CTNM N/A
  • Revenue Next Year
  • EBMT $5.11
  • CTNM N/A
  • P/E Ratio
  • EBMT $11.53
  • CTNM N/A
  • Revenue Growth
  • EBMT 0.06
  • CTNM N/A
  • 52 Week Low
  • EBMT $12.61
  • CTNM $3.35
  • 52 Week High
  • EBMT $18.49
  • CTNM $21.58
  • Technical
  • Relative Strength Index (RSI)
  • EBMT 41.75
  • CTNM N/A
  • Support Level
  • EBMT $15.96
  • CTNM N/A
  • Resistance Level
  • EBMT $17.31
  • CTNM N/A
  • Average True Range (ATR)
  • EBMT 0.42
  • CTNM 0.00
  • MACD
  • EBMT -0.10
  • CTNM 0.00
  • Stochastic Oscillator
  • EBMT 28.74
  • CTNM 0.00

About EBMT Eagle Bancorp Montana Inc.

Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: